Role of MAIT cells in gastrointestinal tract bacterial infections in humans: More than a gut feeling

• Published in: Mucosal immunology Vol. 16; no. 5; pp. 740 - 752
• Main Authors: Zheng, Yichao, Han, Fei, Ho, Amanda, Xue, Yiting, Wu, Zhengyu, Chen, Xingchi, Sandberg, Johan K., Ma, Shaohua, Leeansyah, Edwin
• Format: Journal Article
• Language: English
• Published: United States Elsevier Inc 01.10.2023
• Subjects: Bacteria; Bacterial Infections; Gastrointestinal Tract; Histocompatibility Antigens Class I - metabolism; Humans; Inflammation; Medicin och hälsovetenskap; Minor Histocompatibility Antigens - metabolism; Mucosal-Associated Invariant T Cells; Riboflavin
• ISSN: 1933-0219; 1935-3456; 1935-3456
• DOI: 10.1016/j.mucimm.2023.06.005

Mucosa-associated invariant T (MAIT) cells are the largest population of unconventional T cells in humans. These antimicrobial T cells are poised with rapid effector responses following recognition of the cognate riboflavin (vitamin B2)-like metabolite antigens derived from microbial riboflavin biosynthetic pathway. Presentation of this unique class of small molecule metabolite antigens is mediated by the highly evolutionarily conserved major histocompatibility complex class I-related protein. In humans, MAIT cells are widely found along the upper and lower gastrointestinal tracts owing to their high expression of chemokine receptors and homing molecules directing them to these tissue sites. In this review, we discuss recent findings regarding the roles MAIT cells play in various gastrointestinal bacterial infections, and how their roles appear to differ depending on the etiological agents and the anatomical location. We further discuss the potential mechanisms by which MAIT cells contribute to pathogen control, orchestrate adaptive immunity, as well as their potential contribution to inflammation and tissue damage during gastrointestinal bacterial infections, and the ensuing tissue repair following resolution. Finally, we propose and discuss the use of the emerging three-dimensional organoid technology to test different hypotheses regarding the role of MAIT cells in gastrointestinal bacterial infections, inflammation, and immunity.